Topic · page 10 of 12

Across rheumatic diseases

Only studies that genuinely span several rheumatic diseases, such as drug safety and pharmacovigilance, infection, vaccination and comorbidity (cardiovascular, cancer, mental health) across diseases, and health services and quality of care across diseases. Never a fallback for an article that is hard to place

Briefs 361–400 of 474 placed here, newest publication first

Briefs in Across rheumatic diseases

Newest publication first

Arthritis Care Res (Hoboken)7 Aug 2023
Social Determinants of Health Documentation Among Individuals With Rheumatic and Musculoskeletal Conditions in an Integrated Care Management Program
Cross-sectional study
RMD Open4 Aug 2023
Fatigue in patients with rheumatic and musculoskeletal diseases: a scoping review on definitions, measurement instruments, determinants, consequences and interventions
Research article
Rheumatology (Oxford)2 Aug 2023
Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study
Cohort study
Arthritis Care Res (Hoboken)30 Jul 2023
Understanding Stakeholders’ Perspectives to Increase COVID‐19 Vaccine and Booster Uptake Among Black Individuals With Rheumatic Conditions
Research article
Rheumatology (Oxford)26 Jul 2023
Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study
Cross-sectional study
Lancet Rheumatol24 Jul 2023
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY
Cross-sectional study
Rheumatology (Oxford)19 Jul 2023
Autoimmune diseases exhibit shared alterations in the gut microbiota
Meta-analysis
Arthritis Care Res (Hoboken)14 Jul 2023
Life Events, Caregiving, and Risk of Autoimmune Rheumatic Diseases in the Women's Health Initiative Observational Study
Cohort study
Rheumatology (Oxford)11 Jul 2023
Trends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021
Cohort study
Ann Rheum Dis6 Jul 2023
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study
Cohort study
Rheumatology (Oxford)22 Jun 2023
Prevalence of LTBI in patients with autoimmune diseases and accuracy of IGRA in predicting TB relapse
Cross-sectional study
Ann Rheum Dis16 Jun 2023
Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database
Cohort study
RMD Open16 Jun 2023
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group
Cohort study
RMD Open9 Jun 2023
Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study
Cohort study
Rheumatology (Oxford)8 Jun 2023
Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients
Cohort study
Semin Arthritis Rheum2 Jun 2023
Offspring neurodevelopmental outcomes born to parents with chronic inflammatory arthritis using antirheumatic therapies: A scoping review
Research article
Ann Rheum Dis1 Jun 2023
Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? Results of a prospective cohort study (iFAME-MTX)
Cohort study
Arthritis Res Ther1 Jun 2023
Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study
Cohort study
Clin Exp Rheumatol1 Jun 2023
Do subjective components of disease activity contribute to heterogeneity in opioid prescriptions in inflammatory rheumatic diseases? Results from ESPOIR and DESIR cohorts
Cohort study
Rheumatology (Oxford)1 Jun 2023
Immune-mediated diseases and risk of incident cardiovascular diseases: a prospective cohort study
Cohort study
BMJ30 May 2023
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK
Cohort study
Ann Rheum Dis29 May 2023
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications
Meta-analysis
Rheumatology (Oxford)25 May 2023
Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2
Cross-sectional study
Rheumatology (Oxford)18 May 2023
Venous and arterial thromboembolic risk of Janus kinase inhibitors: a systematic review with meta-analysis
Meta-analysis
Joint Bone Spine16 May 2023
Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases
Guideline or statement
J Rheumatol15 May 2023
Online Patient-Reported Outcome Measure Engagement Is Dependent on Demographics and Locality: Findings From an Observational Cohort
Cohort study
Arthritis Care Res (Hoboken)15 May 2023
Beliefs, Experiences, and Openness Regarding Dietary Interventions: Data From an Urban Hispanic Population With Rheumatic Disease in the US
Cross-sectional study
Semin Arthritis Rheum11 May 2023
Living with foot and ankle disorders in rheumatic and musculoskeletal diseases: A systematic review of qualitative studies to inform the work of the OMERACT Foot and Ankle Working Group
Meta-analysis
Lancet5 May 2023
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
Cohort study
Semin Arthritis Rheum4 May 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session
Research article
Scand J Rheumatol4 May 2023
Physical therapy in patients with rheumatoid arthritis and axial spondyloarthritis: the patients’ perspective
Cross-sectional study
RMD Open24 Apr 2023
Population-based user-perceived experience of Rheumatic?: a novel digital symptom-checker in rheumatology
Cross-sectional study
RMD Open17 Apr 2023
Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases
Cross-sectional study
Clin Exp Rheumatol16 Apr 2023
Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients
Cohort study
Arthritis Care Res (Hoboken)11 Apr 2023
RheumMadness: Creating an Online Community of Inquiry in Rheumatology
Cross-sectional study
Semin Arthritis Rheum6 Apr 2023
Self-management support needs of patients with inflammatory arthritis and the content of self-management interventions: a scoping review
Research article
Rheumatology (Oxford)5 Apr 2023
Cost-effectiveness of cognitive behavioural and personalized exercise interventions for reducing fatigue in inflammatory rheumatic diseases
Randomized controlled trial
Rheumatology (Oxford)5 Apr 2023
COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER Project
Cohort study
Clin Exp Rheumatol4 Apr 2023
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey
Guideline or statement
Semin Arthritis Rheum31 Mar 2023
Perioperative treatment with TNF inhibitors does not affect survival of total hip arthroplasty in inflammatory arthritis: A registry-based cohort study
Cohort study

All 474 Briefs in ExploreShowing Briefs 361–400 of 474, newest first